gsk alpha regulates production alzheimers disease amyloid-beta peptides 
alzheimers disease associated increased production aggregation amyloid-beta abeta peptides abeta peptides derived amyloid precursor protein app sequential proteolysis catalysed aspartyl protease bace followed presenilin-dependent gamma-secretase cleavage presenilin interacts nicastrin aph pen ref required gamma-secretase function presenilins also interact alpha-catenin beta-catenin glycogen synthase kinase-3beta gsk-3beta- functional role proteins gamma-secretase activity established show therapeutic concentrations lithium gsk inhibitor block production abeta peptides interfering app cleavage gamma-secretase step inhibit notch processing importantly lithium also blocks accumulation abeta peptides brains mice overproduce app target lithium setting gsk-3alpha required maximal processing app since gsk also phosphorylates tau protein principal component neurofibrillary tangles inhibition gsk-3alpha offers new approach reduce formation amyloid plaques neurofibrillary tangles two pathological hallmarks alzheimers disease 
